Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-11

FDA Approved: FLUORODOPA F18 — Supplemental Application (THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH)

View source ↗

Summary

FDA approved a supplemental application for Fluorodopa F18, enabling updated labeling/indications for its use in brain PET imaging. The approval was issued to T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUORODOPA F18 (Fluorodopa F-18)

Snippet

SUPPL AP for FLUORODOPA F18 (FLUORODOPA F18)